SCHEMBL4018763

SCHEMBL4018763

O=C(O)OC1CC2CCCCC2CN1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
PKM P14618 1/20 0.33
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364115 1.00 L3MBTL1 (0.41) L3MBTL1SLC1A2SLC1A1PKMDPP4
SCHEMBL9664087 0.81 L3MBTL1 (0.45) L3MBTL1
SCHEMBL10753923 0.75
SCHEMBL2460430 0.74 CHRM2 (0.35)
SCHEMBL10818536 0.74 CHRM2 (0.35)
SCHEMBL6578062 0.74 CHRM2 (0.35)
SCHEMBL10588318 0.74 CHRM2 (0.35)
SCHEMBL5183989 0.74 CHRM2 (0.35)
SCHEMBL10817753 0.74 CHRM2 (0.35)
SCHEMBL9326179 0.74 CHRM2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854140-B1 Vitronectin receptor antagonists, their production and their use SANOFI AVENTIS DEUTSCHLAND (DE) 2013-11-06 EP disclosed
EP-0903353-B1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them SANOFI AVENTIS DEUTSCHLAND (DE) 2009-11-25 EP disclosed
EP-0820988-B1 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists HOECHST AG (DE) 2009-07-01 EP disclosed
EP-0842944-B1 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4 HOECHST AG (DE) 2003-07-09 EP disclosed
EP-0918059-B1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them AVENTIS PHARMA GMBH (DE) 2003-06-25 EP disclosed
EP-0842943-B1 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists HOECHST AG (DE) 2003-02-26 EP disclosed
EP-0842945-B1 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4 HOECHST AG (DE) 2003-02-19 EP disclosed
EP-0739898-B1 Phosphonomonoester nucleic acids, methods for their preparation and their use AVENTIS PHARMA GMBH (DE) 2001-09-26 EP disclosed
EP-1077994-A1 IMIDAZOLIDINE DERIVATIVES, THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME Aventis Pharma Deutschland GmbH (DE) 2001-02-28 EP disclosed
WO-1999060015-A1 IMIDAZOLIDINE DERIVATIVES, THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-11-25 WO disclosed
WO-1992008709-A1 META-SUBSTITUTED PHENYL ALANINE DERIVATIVES PENTAPHARM AG (CH) 1992-05-29 WO disclosed
EP-0475184-A1 Process for the production of peptides by solid phase synthesis HOECHST AKTIENGESELLSCHAFT (DE) 1992-03-18 EP disclosed
EP-0455133-A2 Peptide antagonists of bradykinin HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-06 EP disclosed
EP-0449079-A2 Hydantoin derivative HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-02 EP disclosed
EP-0435059-A1 Retroviral protease inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-03 EP disclosed
EP-0428849-A2 Retroviral protease inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-29 EP disclosed
EP-0413277-A1 Peptide antagonists of bradykinin HOECHST AKTIENGESELLSCHAFT (DE) 1991-02-20 EP disclosed
EP-0117447-B1 CYCLIC PEPTIDES WITH SOMATOSTATIN ACTIVITY HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-09 EP disclosed
EP-0117447-A1 Cyclic peptides with somatostatin activity HOECHST AKTIENGESELLSCHAFT (DE) 1984-09-05 EP disclosed
EP-0052870-A1 Amino acid derivatives and processes for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1982-06-02 EP disclosed